Metophyma

Metophyma
Synonyms
Pronounce	N/A
Specialty	Dermatology
Symptoms	Nasal swelling, thickening of the skin, redness
Complications	Nasal obstruction, cosmetic concerns
Onset	Middle age
Duration	Chronic
Types	N/A
Causes	Unknown, associated with rosacea
Risks	Genetics, alcohol consumption, sun exposure
Diagnosis	Clinical examination, biopsy
Differential diagnosis	Rhinophyma, rosacea, sebaceous hyperplasia
Prevention	N/A
Treatment	Laser therapy, surgical excision, dermabrasion
Medication	Isotretinoin, antibiotics
Prognosis	N/A
Frequency	Rare
Deaths	N/A

Metophyma is a skin disorder characterized by an overgrowth of sebaceous glands. It is a subtype of Rosacea, a chronic skin condition that primarily affects the face. Metophyma is most commonly seen in men and is often associated with alcohol consumption, although this is not always the case.

Symptoms

The primary symptom of Metophyma is a thickening of the skin on the nose, leading to an enlarged, bulbous appearance. This can also occur on other parts of the face, including the forehead, chin, and ears. Other symptoms may include redness, inflammation, and the presence of pustules or papules.

Causes

The exact cause of Metophyma is unknown, but it is believed to be related to the chronic inflammation associated with Rosacea. Factors that may contribute to the development of Metophyma include alcohol consumption, sun exposure, and genetic predisposition.

Diagnosis

Diagnosis of Metophyma is typically based on a physical examination of the skin. In some cases, a skin biopsy may be performed to rule out other conditions.

Treatment

Treatment for Metophyma often involves surgery to reduce the size of the nose. This can be done through various methods, including laser surgery, dermabrasion, or electrosurgery. In some cases, topical or oral medications may be used to reduce inflammation and redness.

See also

• Rosacea
• Sebaceous gland
• Dermabrasion
• Electrosurgery

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia